Biotech News

Atara Biotherapeutics Provides a Business Update

Atara Biotherapeutics, Inc. (ATRA)Atara Biotherapeutics, Inc.Company update

ATRA (ATRA) appears in the live feed after a catalyst-style update. The headline is surfaced in real time so readers can move from signal to source without leaving the product flow.

The source domain is atra.com. BioPharmSignal keeps the ticker, timestamp, and source together for faster review before the wider market catches up.

The original release is available below in a new tab so readers can continue into the full source when needed.

Related news

Atara Biotherapeutics, Inc.

Allogeneic EBV T-Cell Platform Atara Biotherapeutics develops off-the-shelf T-cell therapies generated from healthy donors and directed against Epstein-Barr virus antigens. Tabelecleucel Tabelecleucel is intended for patients with Epstein-Barr virus-positive post-transplant lymphoproliferative disease and is supported by the pivotal...

Recent company news

Stock data

Close
8.25 USD
Market cap
89.2M USD
Exchange
NASDAQ
Sector
Biopharma
Location
United States